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ABSTRACT
Objectives: There is a clinical impression of dissatisfaction
with treatment for hypothyroidism among some patients.
Psychometric properties of the new ThyTSQ questionnaire
are evaluated. The questionnaire, measuring patients’ satis-
faction with their treatment for hypothyroidism, has two
parts: the seven-item ThyTSQ-Present and four-item
ThyTSQ-Past, measuring satisfaction with present and past
treatment, respectively, on scales from 6 (very satisﬁed) to 0
(very dissatisﬁed).
Methods: The questionnaire was completed once by 103
adults with hypothyroidism, age (mean [SD]) 55.2 [14.4],
range 23–84 years (all treated with thyroxine).
Results: Completion rates were very high. Internal consist-
ency reliability was excellent for both ThyTSQ-Present and
ThyTSQ-Past (Cronbach’s alpha = 0.91 and 0.90, respec-
tively [N = 102 and 103]). Principal components analyses
indicated that the seven items of the ThyTSQ-Present and the
four items of the ThyTSQ-Past could be summed into sepa-
rate Present Satisfaction and Past Satisfaction total scores.
Mean Present Satisfaction was 32.5 (7.8), maximum range
0–42, and mean Past Satisfaction was 17.5 (6.1), maximum
range 0–24, indicating considerable room for improvement.
Patients were least satisﬁed with their present understanding
of their condition, mean 4.2 (1.7) (maximum range 0–6), and
with information provided about hypothyroidism around the
time of diagnosis, mean 3.9 (1.8) (maximum range 0–6).
Conclusions: The ThyTSQ is highly acceptable to patients
with hypothyroidism (excellent completion rates), and has
established internal consistency reliability. It will assist health
professionals in considering psychological outcomes when
treating people with hypothyroidism, and is suitable for clin-
ical trials and routine clinical monitoring.
Keywords: hypothyroidism, questionnaire, thyroxine, treat-
ment satisfaction, validation.
Introduction
Hypothyroidism is a common chronic endocrine dis-
order [1,2] with physical symptoms associated with
slowing of the metabolism, such as weight gain or cold
intolerance, and also psychological symptoms, includ-
ing reduced cognitive functioning [3]. The standard
treatment is thyroxine (T4) replacement therapy which
is converted to the more metabolically active triio-
dothyronine (T3) in the peripheral tissues [4]. This
treatment returns patients to a biochemical euthyroid
state, with normal levels of thyroid stimulating hor-
mone (TSH) concentration and serum Free T4 (FT4).
Nevertheless, some patients continue to report persist-
ent symptoms despite their TSH and FT4 levels being
within the reference ranges indicating that their T4
replacement is adequate [5]. For example, one study
found that the number of individuals with signiﬁcant
impairment in psychological well-being was 21%
higher in thyroxine-treated patients than euthyroid
controls of similar age and sex, even though patients’
TSH levels were within the normal laboratory refer-
ence range [6]. Some patients report increased well-
being only with slightly elevated FT4 and low or
undetectable TSH [7]. There is much controversy
about the interpretation of TSH levels and appropriate
T4 dosage to alleviate persistent symptoms but avoid-
ing possible long-term effects of excessive T4 replace-
ment (osteoporosis and heart disease) [8], and whether
to treat those with subclinical hypothyroidism or not
[9,10] or add T3 to the standard T4 therapy [11].
Patients may express their dissatisfaction with
treatment in patients’ newsletters (e.g., British Thyroid
Foundation) and there are anecdotal reports from cli-
nicians of continuing dissatisfaction in some of their
patients [12]. Poor adherence to treatment by patients
is not uncommon [13], perhaps reﬂecting dissatisfac-
tion with the treatment. Walsh deﬁned dissatisfaction
with thyroxine therapy as “persistence or recurrence
of symptoms of hypothyroidism despite apparently
adequate thyroxine replacement” and remarked that
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its prevalence among thyroxine-treated patients was
not known and that further research in this “neglected
area” should be encouraged [12]. A questionnaire
measuring patients’ satisfaction with treatment for
hypothyroidism has been designed recently: the
Underactive Thyroid Treatment Satisfaction Question-
naire (ThyTSQ) [14], the ﬁrst known measure of its
kind for patients with hypothyroidism. During the
qualitative design stage of the ThyTSQ design work,
semistructured interviews were conducted with 38
patients, interviews in which patients talked about
their experiences of treatment and completed and
commented on the draft questionnaire. Possible
changes were discussed and new or modiﬁed items
piloted with subsequent patients. Weak draft items
were eliminated at this stage and checks made that
instructions and questions were understood and
responded to easily. Although the aim was to design a
measure of patients’ satisfaction with their current
treatment for hypothyroidism, half the patients in the
early interviews (10/20) spontaneously reported nega-
tive experiences of treatment around the time of diag-
nosis. These negative experiences related to delays in
diagnosis, and/or in prescribing thyroxine treatment,
and/or lack of information provided about the condi-
tion or the treatment. Even though patients’ experi-
ence of current treatment might be positive, in some
cases these past negative experiences interfered with
completion of questions about current treatment,
because patients wanted to express their dissatisfac-
tion with earlier treatment/perceived mistreatment. A
separate section was therefore drawn up, after half the
interviews had been conducted, with questions cover-
ing satisfaction with past  treatment  around  the  time
of diagnosis, the ThyTSQ-Past. It is an extension of
the main questionnaire, the ThyTSQ-Present, which
measures satisfaction with current treatment. The
design of the ThyTSQ is based on the widely used Dia-
betes Treatment Satisfaction Questionnaire (DTSQ)
[15–17] and related questionnaires for people with
renal disease (RTSQ) [18], Human Immunodeﬁciency
Virus (HIVTSQ) [19], and diabetic retinopathy
(RetTSQ) [20], but hypothyroidism is the ﬁrst disor-
der for which it has been found necessary, at the
design stage, to produce a separate section on past
satisfaction with early treatment around the time of
diagnosis.
The psychometric properties of the ThyTSQ (factor
structure, and aspects of reliability and validity) need
to be evaluated so that the new measure may be used
to identify patients dissatisﬁed with their current treat-
ment regimen and in clinical trials of any new treat-
ments or treatment combinations in the future. This
was undertaken in a cross-sectional survey of patients
in  Gateshead,  UK.  The  Gateshead  Local  Research
Ethics Committee gave approval for the study and
patients provided their informed consent.
Methods
The ThyTSQ
The ThyTSQ-Present has seven items including ques-
tions about satisfaction with current treatment, and
control of symptoms of underactive thyroid (Table 1).
Instructions ask patients to consider their experience
of treatment for underactive thyroid over the previous
few weeks. Patients respond to each item by circling a
number on a scale from 6 to 0 (where 3 is considered
a neutral option), indicating their degree of satisfaction
with that aspect of treatment, for example, from very
satisﬁed to very dissatisﬁed, as in the following exam-
ple (item 1 of the ThyTSQ-Present):
How satisﬁed are you with the current treatment
for your underactive thyroid?
very satisﬁed 6 5 4 3 2 1 0 very dissatisﬁed
The ThyTSQ-Past has four items concerning satis-
faction with the way doctors dealt with the patient or
the thyroid condition around the time of diagnosis,
and satisfaction with information provided about the
condition and its treatment (Table 1). Instructions
inform respondents that the items are concerned with
their early experiences both before and after they were
told they had underactive thyroid. At the end of each
part there is a “free comments” section in which
respondents are asked if there are any other features of
their treatment (i.e., recent treatment [ThyTSQ-
Present], or early treatment [ThyTSQ-Past]) causing
either satisfaction or dissatisfaction, that have not been
covered by the questionnaire. These open sections
allow for the addition of further domains to the ques-
tionnaire in the future, if necessary, for its continuing
development.
Recruitment
Study participants were recruited from the Diabetes
and Endocrinology Clinic at the Queen Elizabeth Hos-
pital Gateshead, UK and three local Primary Care
Practices. Inclusion criteria: age 18+ years (no upper
limit); a diagnosis of hypothyroidism on the basis of
two blood tests taken at least three months apart, that
is, no patient had transient hypothyroidism. People
with mental health problems that would render them
incapable of understanding and completing the ques-
tionnaire were excluded from the study.
Statistical Analyses
Normality of distributions was determined through
investigation of histograms and z (skew) scores, where
z (skew) scores within ±2.58 are indicative of normal-
ity [21]. Cronbach’s alpha coefﬁcient of internal con-
sistency reliability was determined [22]. An alpha of
0.8 was taken as the minimum acceptable [23], but 0.9
was preferable because it is considered by some to be
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the minimum for making decisions about individuals
[24]. Acceptable item–total correlations were those
≥0.2 [25]. Factor structure was explored using princi-
pal components analysis. Salient loadings were taken
as ≥0.4. This is higher than the recommended mini-
mum 0.3 [26], erring on the side of caution in an effort
to reduce the risk of spurious loadings that owed their
origin to any non-normality of item distributions, and
also to avoid double loadings. A minimum of ﬁve
respondents per questionnaire item is required for fac-
tor analysis [27], and the obtained sample size (103)
was more than sufﬁcient to factor analyze the two
parts of the ThyTSQ (containing seven and four items
separately or 11 combined together) [26].
Exploratory correlations were undertaken between
ThyTSQ variables and age, and with biomedical vari-
ables: body mass index (BMI), duration of hypothy-
roidism, and the most recent available TSH
measurement obtained from biochemical thyroid func-
tion tests. Insufﬁcient data were obtained on FT4
measurements (see Results) and these were not
included in correlational analysis. Correlations were
investigated using Pearson’s r for normally distributed,
and Spearman’s rho for skewed data. Subgroup anal-
yses explored differences in sex, and cause of hypothy-
roidism (autoimmune  vs.  iatrogenic),  using  t-test
or Mann–Whitney test for normally distributed and
skewed data, respectively, and differences in TSH level
(within the reference range, above or below this range)
using Univariate Analysis of Variance (ANOVA).
Because this was an exploratory study, the Bonferroni
correction for “familywise” error in multiple tests was
not performed. Means are reported as mean (SD).
Two-tailed signiﬁcance applied. Analyses were con-
ducted using SPSS for Windows Version 9 (SPSS Inc,
Chicago, IL, U.S.A.).
Results
Recruitment
Of the 130 patients invited to complete the ThyTSQ,
103 accepted and returned completed questionnaires
(an acceptance rate of 79%): Queen Elizabeth Hospi-
tal (40 patients), and three local primary care practices
(A, B, and C) (providing 9, 6, and 48 patients, respec-
tively). There were four methods of recruitment: face-
to-face (20%), letter (48%), telephone (1%), and
combined letter plus telephone (31%).
Questionnaire Completion Rates
Completion rates for the ThyTSQ were >99.8%
whether at the hospital, where health-care profession-
als prompted respondents to complete any missed
items on the questionnaires, or at the three primary
care clinics (where patients were not prompted to com-
plete missing data). The Flesch Reading Ease statistic
[28] was calculated to be 54.1 (ThyTSQ-Present) and
57.2 (ThyTSQ-Past). These are slightly less than the
optimal 60–70 (in a possible score range of 0–100,
where a higher score indicates greater reading ease).
Table 1 ThyTSQ items and their response options, with item means
No. Abbreviation ThyTSQ-Present item wording Response options Mean (SD) Median N
1 Present 
satisfaction
How satisﬁed are you with the current treatment for 
your underactive thyroid?
Very satisﬁed–very 
dissatisﬁed
4.89 (1.27) 5 103
2 How well working How well do you feel the treatment is working? Very well–very badly 4.22 (1.47) 4 102
3 Convenient How convenient have you found your treatment to 
be recently (e.g., remembering to take the 
medication, getting prescriptions)?
Very convenient–very 
inconvenient
5.24 (1.18) 6 103
4 Understanding
of condition
How satisﬁed are you with your understanding of 
your underactive thyroid?
Very satisﬁed–very 
dissatisﬁed
4.19 (1.73) 5 103
5 Encourage Would you encourage someone else with underactive 
thyroid to have your kind of treatment?
Yes, I would deﬁnitely
encourage them–no, 
I would deﬁnitely not 
encourage them
5.10 (1.26) 6 103
6 Controlling 
symptoms
How well do you feel that the treatment is controlling 
symptoms of underactive thyroid?
Very well–very badly 4.36 (1.27) 4 103
7 Continue How satisﬁed would you be to continue with your 
present treatment and dose?
Very satisﬁed–very 
dissatisﬁed
4.52 (1.43) 5 103
ThyTSQ-Past item wording
How satisﬁed were you 
1 Past satisfaction . . . with the way doctors dealt with your underactive 
thyroid around the time it was ﬁrst diagnosed?
Very satisﬁed–very 
dissatisﬁed
4.72 (1.68) 5 103
2 Information-
condition
. . . with the information provided by doctors about 
underactive thyroid?
Very satisﬁed–very 
dissatisﬁed
3.94 (1.80) 4 103
3 Information-
treatment
. . . with the information provided by doctors about the 
treatment for underactive thyroid?
Very satisﬁed–very 
dissatisﬁed
4.20 (1.72) 4 103
4 Taken seriously . . . that doctors took you and your underactive 
thyroid seriously?
Very satisﬁed–very 
dissatisﬁed
4.59 (1.78) 5 103
ThyTSQ-Present © Prof Clare Bradley: 22.7.03.
ThyTSQ-Past © Prof Clare Bradley: 22.7.03.
The ThyTSQ scores range from 6 (very satisﬁed) to 0 (very dissatisﬁed).
For access to questionnaire see ThyTSQ Copyright section.
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The Flesch statistic takes into account the average
number of syllables per word and words such as
“underactive” and “dissatisﬁed,” having four sylla-
bles, detract from the score although are not found to
be difﬁcult words. The high completion rates, however,
indicated that the questionnaire was readily under-
stood by this sample of respondents.
The Study Sample Characteristics
The average age of the sample was 55.2 (SD 14.4)
years, with a mean duration of hypothyroidism of 8.7
(9.1) years. The great majority of patients had autoim-
mune hypothyroidism (88%) of whom four patients
had subclinical hypothyroidism. All patients were
receiving thyroxine replacement. The ratio of women
to men was 85:18, similar to the sex ratio of thyroid
disease found in the general US population in a recent
study [2]. Recent measurements of TSH levels were
available for 88 patients but, in the case of FT4 levels,
only 43 patients (42%) as FT4 levels are only meas-
ured if the TSH levels are outside the reference range.
See Table 2 for full details of the sample characteris-
tics. Details are available for 18 of the 27 people who
did not respond to the invitation to complete the ques-
tionnaire. They were all white women, with a mean
age of 53.4 (11.5) years (not signiﬁcantly different
from the age of the participants, P = 0.63).
Analyses, using methods adopted elsewhere [29],
showed that there were no systematic differences in the
data from the four recruitment sources, and that these
data could be treated as one for the purposes of relia-
bility and factor analysis, where larger N is desirable
(full results not reported).
Reliability and Factor Analyses
The seven-item ThyTSQ-Present had very high internal
consistency reliability (Cronbach’s alpha = 0.907,
standardized item alpha = 0.914 [N = 102]). All cor-
rected item–total correlations were satisfactory, the
lowest being 0.504 (item 4: understanding of condi-
tion), which was also the only item to increase overall
scale alpha if deleted (alpha if item deleted was 0.925)
and therefore detract slightly from the scale reliability
while broadening the content. The four-item ThyTSQ-
Past had high internal consistency reliability (Cron-
bach’s alpha = 0.896, standardized item alpha = 0.896
[N = 103]). All corrected item–total correlations were
satisfactory, the lowest being 0.692 (item 1: past sat-
isfaction). No item detracted from the ThyTSQ-Past
scale alpha.
An unforced principal components analysis, con-
ducted on the 11 items (transformed to near normal-
ity), of the two questionnaires combined, produced
two clean factors: Component 1 had all ThyTSQ-
Present items loading >0.65; Component 2 had all four
ThyTSQ-Past items loading >0.82 (Table 3). Separate
unforced principal components analyses of both
ThyTSQ-Present and ThyTSQ-Past variables produced
single components with an eigenvalue >1, accounting
for 63.8% (ThyTSQ-Present) and 77.2% (ThyTSQ-
Past) of the variance (Table 3). This indicated that all
seven ThyTSQ-Present items could be summed into a
ThyTSQ-Present Satisfaction score (range 0–42) and
all four ThyTSQ-Past items could be summed into a
separate ThyTSQ-Past Satisfaction score (range 0–24).
A lower score indicates greater dissatisfaction with
treatment, and a higher score indicates greater satis-
faction with treatment. We do not recommend sum-
ming the Present and Past Satisfaction scores into an
overall Treatment Satisfaction score for the two sec-
tions combined. The correlation between the Past and
Present Satisfaction scores was rho = 0.649, P < 0.001,
N = 102, an indication that the two scales are not
measuring the same construct, as a correlation <0.7
Table 2 Characteristics of ThyTSQ respondents (N = 103)
Mean (SD) [range] N
Mean age (years) 55.2 (14.4) [23–84] 103
Mean duration of hypothyroidism (years) 8.7 (9.1) [0.25–57] 96
Age at leaving full-time education (years) 16.2 (2.5) [14–27] 87
BMI (kg/m2) 28.6 (6.2) [18–48.8] 92
TSH (mU/L) 3.8 (5.2) [0.02–28.7] 88
FT4 (pmol/L) 18.0 (4.4) [8.9–28.4] 43
Ratio women to men 85:18
Ratio white to nonwhite 102:1
Hypothyroidism
Autoimmune 87
Secondary to treatment for thyroid cancer or hyperthyroidism 9
Secondary to lithium treatment 1
Secondary to amiodarone treatment 2
Subclinical (autoimmune)* 4
Comorbid conditions occurring in two or more patients: ischemic heart disease (9), osteoarthritis (9), Type 2 diabetes (8), asthma (7), Type 1 diabetes (6), rheumatic disorder
(6), cancer (4), pregnancy (4), Addison’s disease (3), depression (3), pernicious anemia (3), celiac disease (2).
*Subclinical hypothyroidism deﬁned as: TSH level >4 mU/L and FT4 level in normal range (9–25 pmol/L) [33].
BMI, body mass index; FT4, free thyroxine; TSH, thyroid stimulating hormone.
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falls short of the convention indicating adequate con-
vergence of scales [30]. Further reliability analyses
were conducted using a method reported previously
[31] that showed calculation of overall ThyTSQ-
Present Satisfaction score was reliable at alpha = 0.9
with no items of missing data and reliable at
alpha = 0.8 with up to two items of missing data, and
ThyTSQ-Past Satisfaction score was reliable at
alpha = 0.8 with no more than one item of missing
data.
Descriptive Statistics
Non-normality (negative skew toward high satisfac-
tion with treatment) was found in most ThyTSQ items
and was dealt with successfully by conducting reﬂect
and log transformations, leaving two items with a
small degree of non-normality (z [skew] = 4.2).
ThyTSQ-Present item means (Fig. 1, Table 1) indicate
that overall patients were satisﬁed with all aspects of
their treatment. Patients were most satisﬁed with con-
venience of treatment (item 3, mean 5.24), and least
satisﬁed with their understanding of their condition
(item 4, mean 4.19). Mean Present Satisfaction was
32.5 (7.8) (maximum possible range 0–42). Of the six
patients (5.9%) who had Present Satisfaction scores of
<21 (expressing dissatisfaction with current treatment)
ﬁve had available TSH measurements: mean 1.64,
range 0.12–3.53, that is, were being treated so that
their TSH levels were within the laboratory reference
range of 0.4–4.0 mU/L. Patients were more satisﬁed
than dissatisﬁed with all four aspects measured by the
ThyTSQ-Past (Fig. 1, Table 1), but had least satisfac-
tion with information provided about the condition or
its treatment at time of diagnosis. Mean Past Satisfac-
tion was 17.5 (6.1) (maximum possible range 0–24).
Nineteen patients (18.4%) had Past Satisfaction scores
<12 indicating overall dissatisfaction with past
treatment.
Table 3 Unforced factor loadings of the ThyTSQ-Present and ThyTSQ-Past
ThyTSQ-Present
Separate analyses* Combined analyses†
Component Component 1 Component 2
1: present satisfaction 0.822 0.823 0.019
2: how well working 0.871 0.866 −0.093
3: convenient 0.653 0.656 0.049
4: understanding of condition 0.661 0.655 −0.131
5: encourage 0.813 0.815 −0.014
6: controlling symptoms 0.874 0.868 −0.139
7: continue 0.863 0.867 0.043
ThyTSQ-Past
1: past satisfaction 0.822 −0.028 0.824
2: information—condition 0.914 −0.107 0.908
3: information—treatment 0.914 −0.055 0.908
4: taken seriously 0.861 0.032 0.858
*Principal components analyses with Varimax rotation conducted on each section (Past and Present) separately and †on the 11 items of the Past and Present sections combined.
Satisfactory loadings (≥0.4).
Figure 1 ThyTSQ item mean satisfaction
ratings.
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Correlations
ThyTSQ-Present item 7: continue correlated negatively
with BMI (rho = −0.23, P = 0.03, N = 92), 3: conven-
ient correlated with TSH levels (rho = −0.22, P = 0.04,
N = 88) indicating that those with high BMI were
more dissatisﬁed to continue their present treatment,
and those with high TSH levels were more dissatisﬁed
with convenience of treatment. Variables 1: present
satisfaction, 2: how well working, 6: controlling symp-
toms and 7: continue all correlated positively with age
(rho values ranged from 0.32 to 0.40, P ≤ 0.001, N
ranging 102–103). ThyTSQ-Past items 1: past satisfac-
tion and 2: information—condition also correlated
with age (rho = 0.23 and 0.21, respectively, P < 0.05)
indicating improved satisfaction with increasing age.
There were no signiﬁcant correlations between the Sat-
isfaction scores and the number of comorbid condi-
tions that patients had or duration of hypothyroidism.
Subgroup Differences in ThyTSQ Variables
The only signiﬁcant subgroup difference found was a
sex difference: women had higher satisfaction with the
control of their hypothyroid symptoms, median 5,
compared with men, median 4 (U = 528.5, P = 0.034).
There were no signiﬁcant differences in ThyTSQ-
Present or Past Satisfaction scores, between respond-
ents whose TSH levels were within the reference range
of 0.4–4.0 mU/L (N = 46), and those below (N = 12),
and above this range (N = 29) (P = 0.092), nor
between those who had autoimmune hypothyroidism
(N = 91) and those with hypothyroidism caused by
treatment (N = 12).
Free Comments Sections
The free comments sections were used by 12 patients
(ThyTSQ-Present) and 19 patients (ThyTSQ-Past), all
of whom expressed dissatisfaction with treatment.
Comments were carefully considered, but analysis
showed that these areas of dissatisfaction were either
already covered in the questionnaires or insufﬁcient
numbers of patients (≤2) mentioned them to justify the
addition of new items. Comments (one respondent in
each case) on the ThyTSQ-Present included: problems
with forgetting to take daily medication (covered by
item 3: convenient, which speciﬁcally mentions
remembering to take the medication), concerns about
treatment dose (lack of stable dose, incorrect dose),
desire for alternative therapies, including more holistic
approaches (all could be covered by 1: present satis-
faction and/or 7: continue). Nine patients (8.7%)
reported dissatisfaction about aspects of the way doc-
tors had dealt with their underactive thyroid around
the time it was ﬁrst diagnosed, including the time taken
to diagnose their thyroid problem or prescribe treat-
ment (six patients), especially if they were “border-
line” between overt and subclinical hypothyroidism
(covered  by  1:  past  satisfaction).  Other  comments
(one respondent in each case) on the ThyTSQ-Past
included: aspects of patients’ understanding of their
condition  or  its  treatment,  for  example,  the  length
of time to reach a satisfactory dosage (covered by 2:
information—condition and 3: information—treat-
ment); or being told that their symptoms were “in the
mind” (covered by 4: taken seriously).
Discussion
We report the psychometric evaluation of the recently
designed ThyTSQ measure of patient satisfaction with
treatment for hypothyroidism. The ThyTSQ-Present
measures satisfaction with present treatment and the
ThyTSQ-Past measures satisfaction with treatment
around the time of diagnosis, but past treatment in the
broader sense of the term, to include medical care and
interactions with health-care professionals. Use of the
ThyTSQ-Past is recommended to avoid any negative
experiences of past treatment interfering with comple-
tion of questions about current treatment, although if
it were used in a clinical trial it might only be com-
pleted once, at baseline (in the present study they were
used together). Use of the ThyTSQ-Present alone with-
out the ThyTSQ-Past would need further psychometric
evaluation. The measure is short and quick to com-
plete, with minimal respondent burden, and the very
high completion rates indicated good acceptability to
respondents. The factor structure was clear. When the
11 items of both sections were combined in one
unforced factor analysis, two clean factors emerged,
with Past and Present items loading on separate fac-
tors. Unforced analyses performed on each separate
section produced one factor each, with very high factor
loadings, which lent support for summing the individ-
ual item scores into Present and Past Satisfaction
scores. The internal consistency reliability of each sec-
tion was also excellent. The moderate correlation
between the total scores of the two parts is an indica-
tion that they are measuring different but related
constructs.
When the free comments were analyzed, they
showed that the areas of dissatisfaction mentioned
were, for the most part, already covered by  the  items
of the questionnaire, suggesting that respondents were
emphasizing or explaining dissatisfaction already
reﬂected in existing items. Insufﬁcient numbers of
patients speciﬁed particular issues to justify the addi-
tion of new items, hence the measure would appear to
have good content validity; however, the measure is
still at a relatively early stage of development, and new
items may be added in the future when more data
become available. Construct validity was not assessed
in this exploratory study because no prior hypotheses
were formulated. The only signiﬁcant subgroup differ-
ence found was that women had higher satisfaction
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than men with the control of their hypothyroid symp-
toms. Satisfaction improved with increasing age for
both Past and Present scores, perhaps because people
expect to have more health problems as they grow
older and, with lower expectations of treatment, are
more likely to be satisﬁed with treatment.
Generally high satisfaction rates were found, but a
small proportion of patients were dissatisﬁed, giving
support to anecdotal reports from clinicians. More
patients expressed dissatisfaction with their present
understanding of the condition and with information
provided about the condition in the past than any
other item on the ThyTSQ-Present and Past, respec-
tively. Although dissatisfaction with thyroxine therapy
has been deﬁned in relation to persistence of symptoms
[12], it is clear, not only from interviews conducted
when developing this questionnaire [14] but also from
the  analyses  presented  here,  that  symptoms  are not
the only aspect causing dissatisfaction. This study has
found support for having the section on satisfaction
with past treatment, and some patients clearly wel-
comed the opportunity to report their dissatisfaction
as evidenced by the larger number of patients using the
free comments section of the ThyTSQ-Past than the
ThyTSQ-Present.
This study has shown that more consideration
needs to be given to the interaction between patient
and doctor at the time of diagnosis. More consultation
time may be required at the point when a patient is ﬁrst
told that they have a condition that requires life-long
treatment. Patients may be too distressed, at the time
they are ﬁrst told they have hypothyroidism, to absorb
much  of  the  information  they  are  given,  especially
as cognitive functioning of people with untreated
hypothyroidism is reduced in some cases [32]. They
may welcome information leaﬂets that they can take
home and study in their own time. Although the daily
tablet regimen in itself is not complicated, some
patients may not understand why their dosage must be
increased slowly until equilibrium is reached between
hypo and hyperthyroidism. Others may be despondent
if treatment does not return them to their previous
state before onset, and not fully adhere to the tablet
treatment regimen. Thus, it is possible that increased
adherence to treatment would result if patients under-
stood their treatment better. Use of the ThyTSQ
questionnaire will pinpoint lack of understanding in
individual patients, who can then receive more help
from health-care professionals.
Although further studies will be needed in the
future to assess test–retest reliability, sensitivity to
change (ThyTSQ-Present only), and construct validity,
the questionnaire is now ready to be used in clinical tri-
als of treatments for hypothyroidism. It can be used
also with individual patients, completed question-
naires forming the basis for discussion between
patients and health-care professionals.
Conclusions
The ThyTSQ is a new self-completion measure of sat-
isfaction with treatment in hypothyroidism with sec-
tions measuring present satisfaction with treatment,
and past satisfaction with treatment around the time of
diagnosis. The questionnaire is performing well: it has
good acceptability to respondents, and excellent inter-
nal consistency reliability. A Satisfaction score is
calculated for each section, ThyTSQ-Present and
ThyTSQ-Past, or individual items can be analyzed sep-
arately if required. The ThyTSQ appears to be a val-
uable tool for use in clinical trials or to use in routine
care of individual patients. Its test–retest reliability and
sensitivity to change now need to be evaluated in clin-
ical trials.
ThyTSQ Copyright
For access to and license to use the ThyTSQ, contact
the copyright holder, Clare Bradley PhD, Professor of
Health Psychology, Health Psychology Research,
Royal Holloway, University of London, Egham,
Surrey, TW20 0EX. Website: http://www.hpr-
international.com
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